ZYME 8-K: Acquisition
Zymeworks
Filed with the SEC on · accession 0001193125-26-453730
ZYME filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +4.0% by the first close after the filing.
Summary of the filing
Zymeworks filed an amendment to its Form 8-K to provide the historical financial statements of Theravance Biopharma and pro forma combined financial information related to its previously completed acquisition of Theravance, which was originally announced on September 23, 2026.
Key details
How ZYME stock reacted
Close before
$29.63
Nov 6, 2026
First close after
+3.98%
$30.81
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ZYME, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZYME?
Click hereFrequently asked questions
What did ZYME file with the SEC on Nov 9, 2026?
ZYME filed a 8-K (Acquisition). Zymeworks filed an amendment to its Form 8-K to provide the historical financial statements of Theravance Biopharma and pro forma combined financial information related to its previously completed acquisition of Theravance, which was originally announced on September 23, 2026.
What does a acquisition mean for ZYME stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ZYME stock react to this filing?
ZYME closed at $29.63 before the filing and $30.81 on Nov 9, 2026 (+3.98%).
Other ZYME SEC filings
Get alerts when ZYME files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days